Home - BrainSonix
BrainSonix has developed and intends to manufacture and market a medical device platform based on the Company’s proprietary Low Intensity Focused Ultrasound Pulse (“LIFUP”) technology to modulate the brain function non-invasively without any harmful or irreversible effects on the brain and body.
Low Intensity Focused Ultrasound Pulse, LIFUP, brain neuromodulation, deep brain stimulation, Repetitive Transcranial Magnetic Stimulation, Alexander Bystritsky, Woody Wurster, Mark Schafer, Alex Korb, BrainSonix, John Marlow
15234
home,page-template,page-template-full_width,page-template-full_width-php,page,page-id-15234,ajax_fade,page_not_loaded,,qode-title-hidden,qode-theme-ver-7.5,wpb-js-composer js-comp-ver-4.5.3,vc_responsive

LOW-INTENSITY FOCUSED ULTRASOUND PULSATION

BrainSonix has developed a medical technology based on proprietary LIFUP technology to modulate the brain function.
About BrainSonix

BrainSonix is a privately held company founded by Dr. Alexander Bystritsky, a renowned psychiatrist and professor at UCLA. Our patented technology platform modulates brain function non-invasively.

LEARN MORE
Our Technology

For the first time in history, we have the power to target specific neuronal circuits using fMRI, identify the malfunctioning circuits using fMRI “feedback” and then repair the circuits by activating or inhibiting them.

LEARN MORE
Research

In preparation to manufacture and market a medical device platform based on our proprietary Low Intensity Focused Ultrasound Pulsation (“LIFUP”) technology, the following research has been completed…

LEARN MORE

TREATMENT OF BRAIN DISORDERS

With virutally no direct competition, our patented technology platform

out-performs all current methods by targeting specific neuronal circuits.

LOW FREQUENCY

NON INVASIVE

DEEP BRAIN PENETRATION

REAL-TIME FEEDBACK

INVESTMENT OPPORTUNITY

Low-Intensity Focused Ultrasound Pulsation has the potential to address multi-billion dollar problems in our society including:

  • Epilepsy
  • Parkinson’s Disease
  • Obsessive Compulsive Disorder
  • Chronic Pain
  • Obesity
INVESTOR INFO